These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 16152690)
81. S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts. Asanuma H; Nakai K; Sanada S; Minamino T; Takashima S; Ogita H; Fujita M; Hirata A; Wakeno M; Takahama H; Kim J; Asakura M; Sakuma I; Kitabatake A; Hori M; Komamura K; Kitakaze M J Mol Cell Cardiol; 2007 May; 42(5):924-30. PubMed ID: 17234208 [TBL] [Abstract][Full Text] [Related]
82. Sites of modification of hemospan, a poly(ethylene glycol)-modified human hemoglobin for use as an oxygen therapeutic. Vandegriff KD; Malavalli A; Mkrtchyan GM; Spann SN; Baker DA; Winslow RM Bioconjug Chem; 2008 Nov; 19(11):2163-70. PubMed ID: 18837531 [TBL] [Abstract][Full Text] [Related]
83. Semisynthetic supra plasma expanders: a new class of therapeutics to improve microcircualtion in sickle cell anaemia. Meng F; Kaul D; Thangaswamy S; Bhutoria S; Gerfen G; Branch C; Intaglietta M; Acharya SA Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):73-82. PubMed ID: 30663492 [TBL] [Abstract][Full Text] [Related]
85. UV resonance Raman study of beta93-modified hemoglobin A: chemical modifier-specific effects and added influences of attached poly(ethylene glycol) chains. Juszczak LJ; Manjula B; Bonaventura C; Acharya SA; Friedman JM Biochemistry; 2002 Jan; 41(1):376-85. PubMed ID: 11772037 [TBL] [Abstract][Full Text] [Related]
86. Influence of PEG-conjugated hemoglobin on tumor oxygenation and response to chemotherapy. Yu M; Han J; Dai M; Cui P; Li H; Liu Q; Xiu R Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(6):551-61. PubMed ID: 19065307 [TBL] [Abstract][Full Text] [Related]
87. Stabilities and properties of multilinked hemoglobins. Olsen KW; Zhang QY; Huang H; Sabaliauskas GK; Yang T Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):283-5. PubMed ID: 1391443 [TBL] [Abstract][Full Text] [Related]
88. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. Winslow RM; Gonzales A; Gonzales ML; Magde M; McCarthy M; Rohlfs RJ; Vandegriff KD J Appl Physiol (1985); 1998 Sep; 85(3):993-1003. PubMed ID: 9729575 [TBL] [Abstract][Full Text] [Related]
89. Probing the conformation of hemoglobin presbyterian in the R-state. Acharya SA; Malavalli A; Peterson E; Sun PD; Ho C; Prabhakaran M; Arnone A; Manjula BN; Friedman JM J Protein Chem; 2003 Apr; 22(3):221-30. PubMed ID: 12962322 [TBL] [Abstract][Full Text] [Related]
91. Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. Vandegriff KD; Malavalli A; Minn C; Jiang E; Lohman J; Young MA; Samaja M; Winslow RM Biochem J; 2006 Nov; 399(3):463-71. PubMed ID: 16813564 [TBL] [Abstract][Full Text] [Related]
92. Induced plasma expander-like properties as a function of PEG-chains on extension arm facilitated PEGylation of albumin: "mushroom to brush-like" conformational transition of the PEG-albumin conjugate. Sahu RK; Nacharaju P; Manjula BN; Acharya SA Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(6):245-56. PubMed ID: 19922165 [TBL] [Abstract][Full Text] [Related]
93. Activation of the low oxygen affinity-inducing potential of the Asn108(beta)-->Lys mutation of Hb-Presbyterian on intramolecular alpha alpha-fumaryl cross-bridging. Manjula BN; Malavalli A; Prabhakaran M; Friedman JM; Acharya AS Protein Eng; 2001 May; 14(5):359-66. PubMed ID: 11438759 [TBL] [Abstract][Full Text] [Related]
94. A novel cross-linking reagent for bovine hemoglobin modification. He M; Lu X; Zhao D; Su Z Biotechnol Lett; 2003 Feb; 25(4):327-30. PubMed ID: 12882546 [TBL] [Abstract][Full Text] [Related]
95. Modern cross-linking strategies for synthesizing acellular hemoglobin-based oxygen carriers. Harris DR; Palmer AF Biotechnol Prog; 2008; 24(6):1215-25. PubMed ID: 19194934 [TBL] [Abstract][Full Text] [Related]
96. A new polyethyleneglycol-derivatized hemoglobin derivative with decreased oxygen affinity and limited toxicity. Zolog O; Mot A; Deac F; Roman A; Fischer-Fodor E; Silaghi-Dumitrescu R Protein J; 2011 Jan; 30(1):27-31. PubMed ID: 21161348 [TBL] [Abstract][Full Text] [Related]
97. Site-selective glycosylation of hemoglobin with variable molecular weight oligosaccharides: potential alternative to PEGylation. Styslinger TJ; Zhang N; Bhatt VS; Pettit N; Palmer AF; Wang PG J Am Chem Soc; 2012 May; 134(17):7507-15. PubMed ID: 22489605 [TBL] [Abstract][Full Text] [Related]
98. Engineering hemoglobin to enable homogenous PEGylation without modifying protein functionality. Cooper CE; Silkstone GGA; Simons M; Gretton S; Rajagopal BS; Allen-Baume V; Syrett N; Shaik T; Popa G; Sheng X; Bird M; Choi JW; Piano R; Ronda L; Bettati S; Paredi G; Mozzarelli A; Reeder BJ Biomater Sci; 2020 Jul; 8(14):3896-3906. PubMed ID: 32539053 [TBL] [Abstract][Full Text] [Related]
99. Lyophilized annelid mega-hemoglobin retains its' quaternary structure and oxygen equilibrium properties after room temperature storage for over 6 months. Savla C; Palmer AF PLoS One; 2022; 17(2):e0263996. PubMed ID: 35176086 [TBL] [Abstract][Full Text] [Related]